Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginTimes Interest Earned

Cellectis (CLLS) Equity Ratio (2016 - 2025)

Cellectis has reported Equity Ratio over the past 12 years, most recently at 0.23 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.23 for Q4 2025, down 31.58% from a year ago — trailing twelve months through Dec 2025 was 0.23 (down 31.58% YoY), and the annual figure for FY2025 was 0.23, down 31.58%.
  • Equity Ratio for Q4 2025 was 0.23 at Cellectis, down from 0.34 in the prior quarter.
  • Over the last five years, Equity Ratio for CLLS hit a ceiling of 0.62 in Q4 2021 and a floor of 0.23 in Q4 2025.
  • Median Equity Ratio over the past 5 years was 0.36 (2023), compared with a mean of 0.39.
  • Biggest five-year swings in Equity Ratio: crashed 47.45% in 2023 and later soared 34.84% in 2024.
  • Cellectis' Equity Ratio stood at 0.62 in 2021, then dropped by 22.1% to 0.48 in 2022, then crashed by 47.45% to 0.25 in 2023, then surged by 34.84% to 0.34 in 2024, then plummeted by 31.58% to 0.23 in 2025.
  • The last three reported values for Equity Ratio were 0.23 (Q4 2025), 0.34 (Q4 2024), and 0.25 (Q4 2023) per Business Quant data.